Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD - Nasdaq - US0953061068 - Common Stock - Currency: USD

55.34  +3.03 (+5.79%)

After market: 55.34 0 (0%)

Fundamental Rating

5

Overall BLBD gets a fundamental rating of 5 out of 10. We evaluated BLBD against 128 industry peers in the Machinery industry. Both the profitability and the financial health of BLBD get a neutral evaluation. Nothing too spectacular is happening here. BLBD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BLBD was profitable.
In the past year BLBD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

BLBD's Return On Assets of 19.89% is amongst the best of the industry. BLBD outperforms 98.43% of its industry peers.
Looking at the Return On Equity, with a value of 56.80%, BLBD belongs to the top of the industry, outperforming 97.64% of the companies in the same industry.
The Return On Invested Capital of BLBD (28.98%) is better than 98.43% of its industry peers.
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROIC 28.98%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

With a decent Profit Margin value of 7.97%, BLBD is doing good in the industry, outperforming 62.20% of the companies in the same industry.
In the last couple of years the Profit Margin of BLBD has grown nicely.
With a Operating Margin value of 9.74%, BLBD perfoms like the industry average, outperforming 51.97% of the companies in the same industry.
In the last couple of years the Operating Margin of BLBD has grown nicely.
With a Gross Margin value of 19.18%, BLBD is not doing good in the industry: 73.23% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BLBD has grown nicely.
Industry RankSector Rank
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BLBD is creating value.
BLBD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BLBD has more shares outstanding
Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 6.55 indicates that BLBD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.55, BLBD belongs to the top of the industry, outperforming 86.61% of the companies in the same industry.
The Debt to FCF ratio of BLBD is 1.07, which is an excellent value as it means it would take BLBD, only 1.07 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BLBD (1.07) is better than 85.83% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that BLBD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.46, BLBD is in line with its industry, outperforming 49.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Altman-Z 6.55
ROIC/WACC3
WACC9.66%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

BLBD has a Current Ratio of 1.45. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
BLBD has a Current ratio of 1.45. This is in the lower half of the industry: BLBD underperforms 77.95% of its industry peers.
A Quick Ratio of 0.73 indicates that BLBD may have some problems paying its short term obligations.
The Quick ratio of BLBD (0.73) is worse than 81.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.73
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.95% over the past year.
The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
The Revenue has grown by 18.92% in the past year. This is quite good.
The Revenue has been growing slightly by 5.74% on average over the past years.
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
Revenue 1Y (TTM)18.92%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%

3.2 Future

The Earnings Per Share is expected to grow by 6.83% on average over the next years.
BLBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.99% yearly.
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue Next Year9.16%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5Y6.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.41, the valuation of BLBD can be described as correct.
BLBD's Price/Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 82.68% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.48, BLBD is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 13.04, the valuation of BLBD can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 82.68% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.04. BLBD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.41
Fwd PE 13.04
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLBD indicates a somewhat cheap valuation: BLBD is cheaper than 68.50% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLBD indicates a somewhat cheap valuation: BLBD is cheaper than 63.78% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.02
EV/EBITDA 11.6
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BLBD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.26
PEG (5Y)0.88
EPS Next 2Y10.42%
EPS Next 3Y6.83%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (8/8/2025, 8:21:10 PM)

After market: 55.34 0 (0%)

55.34

+3.03 (+5.79%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners119.23%
Inst Owner Change-1.66%
Ins Owners0.55%
Ins Owner Change0.19%
Market Cap1.75B
Analysts83.08
Price Target52.6 (-4.95%)
Short Float %16.34%
Short Ratio13.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.87%
Min EPS beat(2)-0.8%
Max EPS beat(2)10.53%
EPS beat(4)3
Avg EPS beat(4)24.77%
Min EPS beat(4)-0.8%
Max EPS beat(4)74.11%
EPS beat(8)7
Avg EPS beat(8)53.29%
EPS beat(12)9
Avg EPS beat(12)-95.09%
EPS beat(16)10
Avg EPS beat(16)-86.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)4.08%
Revenue beat(12)8
Avg Revenue beat(12)5.72%
Revenue beat(16)10
Avg Revenue beat(16)4.68%
PT rev (1m)0%
PT rev (3m)-2.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 14.41
Fwd PE 13.04
P/S 1.29
P/FCF 20.02
P/OCF 15.81
P/B 9.18
P/tB 13.55
EV/EBITDA 11.6
EPS(TTM)3.84
EY6.94%
EPS(NY)4.24
Fwd EY7.67%
FCF(TTM)2.76
FCFY5%
OCF(TTM)3.5
OCFY6.33%
SpS42.96
BVpS6.03
TBVpS4.08
PEG (NY)1.26
PEG (5Y)0.88
Profitability
Industry RankSector Rank
ROA 19.89%
ROE 56.8%
ROCE 41.65%
ROIC 28.98%
ROICexc 49.31%
ROICexgc 73.58%
OM 9.74%
PM (TTM) 7.97%
GM 19.18%
FCFM 6.44%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.49
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1.07
Debt/EBITDA 0.59
Cap/Depr 152.12%
Cap/Sales 1.71%
Interest Coverage 12.82
Cash Conversion 75.01%
Profit Quality 80.71%
Current Ratio 1.45
Quick Ratio 0.73
Altman-Z 6.55
F-Score8
WACC9.66%
ROIC/WACC3
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.95%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%30.77%
EPS Next Y11.4%
EPS Next 2Y10.42%
EPS Next 3Y6.83%
EPS Next 5YN/A
Revenue 1Y (TTM)18.92%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%19.39%
Revenue Next Year9.16%
Revenue Next 2Y8.58%
Revenue Next 3Y5.57%
Revenue Next 5Y6.99%
EBIT growth 1Y7.72%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year39.1%
EBIT Next 3Y15.17%
EBIT Next 5Y14.15%
FCF growth 1Y249.42%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y248.76%
OCF growth 3YN/A
OCF growth 5Y14.81%